Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000375119

Medchemexpress LLC DNQX | 2379-57-9 | C8H4N4O6 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY1506750MG

Encompass_Preferred

DNQX (FG 9041) is a quinoxaline derivative that acts as a selective, potent competitive non-NMDA glutamate receptor antagonist. It exhibits IC50 values of 0.5 μM for AMPA receptors, 2 μM for kainate receptors, and 40 μM for NMDA receptors.

  • Selective non-NMDA glutamate receptor antagonist
  • Potent competitive antagonist
  • IC50s: 0.5 μM (AMPA), 2 μM (kainate), 40 μM (NMDA)
  • High purity (99.67%)
  • Available as solid and solution
  • In vivo dissolution protocols provided
  • In vitro, depolarizes thalamic reticular nucleus (TRN) neurons
  • In vivo, diminishes phencyclidine (PCP) hsp70 induction

Catalog No. 50-003-75119


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.